98% Citicoline Sodium, Factory Supply Pharmaceutical Raw Material CAS 33818-15-4

Brand: GSHWORLD
Quantity:
In Stock
98% Citicoline Sodium, Factory Supply Pharmaceutical Raw Material CAS 33818-15-4, Find Details and Price about Sodium Citicoline Sodium from 98% Citicoline Sodium, Factory Supply Pharmaceutical Raw Material CAS 33818-15-4 - Anhui GSH Bio-Technology Co., Ltd.
Samples: US$ 0/Bag
Supplier Present:
  GSH Bio-Tech global pioneer in enzymatic catalytic ATP regeneration technology, committed to providing customers with better and more environmentally friendly products and services.

98% Citicoline Sodium, Factory Supply Pharmaceutical Raw Material CAS 33818-15-4

98% Citicoline Sodium, Factory Supply Pharmaceutical Raw Material CAS 33818-15-4

Citicoline Sodium manufacturer / Citicoline Sodium Factory / China Citicoline manufacturers / Citicoline suppliers

Model NO.Citicoline Sodium
ColourWhite
Storage ConditionCool and Dry Shade
MSDSAvailable
ODM or OEMAvailable
UsagePharmaceutical Intermediate
GradePharmaceutical Grade
Transport Package25kg/Drum 1kg/Drum
Specification98%-101%
OriginChina
HS Code2942000000
Production Capacity20 Ton/Month

Citicoline sodium (CDPC) is an endogenous nucleoside naturally produced in the body. The repair of nerve cell membranes requires alarge amount of citicoline sodium. It has the functions of repairing brain damage and anti-oxidation, and has been widely used in clinical.

Application

Citicoline is amultimodal agent that has demonstrated neuroprotective and neuroregenerative effects in various experimental and clinical disorders of the central nervous system, including acute and chronic cerebral ischemia, cerebral hemorrhage, and global cerebral hypoxia. It provides neuroprotection by attenuating glutamate excitotoxicity, oxidative stress, apoptosis, and blood-brain barrier dysfunction.


In recent years, in addition to being used in brain surgery and traumatic brain injury, it is also used in the auxiliary treatment of function and consciousness, tremor paralysis, tinnitus and nervous deafness, glaucoma and amblyopia caused by acute injury of the central nervous system.


Citicoline may also act as an adjuvant therapy and prevent cognitive decline and other neurological complications associated withdisease 2019.


CDPC can be administered intravenously, intramuscularly or orally: after administration, citicoline sodium is catabolized relatively quickly and is the source of choline in the blood. After oral administration, citicoline sodium is rapidly absorbed and then hydrolyzed into choline and cytidine in the intestinal wall and liver; thus, in addition to providing metabolic precursors of phospholipids, it also enters the synthesis pathways of nucleic acids, proteins and acetylcholine.


Today, citicoline is available as an oral, intravenous infusion, intramuscular injection, and eye drops.


Product Properties

Citicoline sodium(C14H25N4NaO11P2)

CAS

33818-15-4

Appearance

White powder

Assay

≥98.0%

Loss on drying

Not more than 1%

Heavy Metal

Not more than 10ppm

Application

Raw material,medicine

Shelf Life

24 months when properly stored.


Packing and transportation
98% Citicoline Sodium, Factory Supply Pharmaceutical Raw Material CAS 33818-15-4

98% Citicoline Sodium, Factory Supply Pharmaceutical Raw Material CAS 33818-15-498% Citicoline Sodium, Factory Supply Pharmaceutical Raw Material CAS 33818-15-498% Citicoline Sodium, Factory Supply Pharmaceutical Raw Material CAS 33818-15-4